SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003477
Filing Date
2021-11-08
Accepted
2021-11-08 16:21:26
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q oric-20210930.htm   iXBRL 10-Q 2772206
2 EX-10.2 oric-ex10_2.htm EX-10.2 188977
3 EX-31.1 oric-ex31_1.htm EX-31.1 17021
4 EX-31.2 oric-ex31_2.htm EX-31.2 17008
5 EX-32.1 oric-ex32_1.htm EX-32.1 10383
6 EX-32.2 oric-ex32_2.htm EX-32.2 10369
  Complete submission text file 0000950170-21-003477.txt   7834440

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oric-20210930_lab.xml EX-101.LAB 353576
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oric-20210930_pre.xml EX-101.PRE 245451
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oric-20210930_def.xml EX-101.DEF 125168
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oric-20210930_cal.xml EX-101.CAL 41108
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oric-20210930.xsd EX-101.SCH 38161
12 EXTRACTED XBRL INSTANCE DOCUMENT oric-20210930_htm.xml XML 1228914
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 211388296
SIC: 2834 Pharmaceutical Preparations